DE69720535D1 - Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon - Google Patents

Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon

Info

Publication number
DE69720535D1
DE69720535D1 DE69720535T DE69720535T DE69720535D1 DE 69720535 D1 DE69720535 D1 DE 69720535D1 DE 69720535 T DE69720535 T DE 69720535T DE 69720535 T DE69720535 T DE 69720535T DE 69720535 D1 DE69720535 D1 DE 69720535D1
Authority
DE
Germany
Prior art keywords
taxoids
reversing
active substance
pharmaceutical preparations
cancer chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69720535T
Other languages
English (en)
Other versions
DE69720535T2 (de
Inventor
Iwao Ojima
J Bernacki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Health Research Inc
Original Assignee
Research Foundation of State University of New York
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York, Health Research Inc filed Critical Research Foundation of State University of New York
Application granted granted Critical
Publication of DE69720535D1 publication Critical patent/DE69720535D1/de
Publication of DE69720535T2 publication Critical patent/DE69720535T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69720535T 1997-01-08 1997-12-29 Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon Expired - Fee Related DE69720535T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/780,633 US5811452A (en) 1997-01-08 1997-01-08 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US780633 1997-01-08
PCT/US1997/024020 WO1998030553A1 (en) 1997-01-08 1997-12-29 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
DE69720535D1 true DE69720535D1 (de) 2003-05-08
DE69720535T2 DE69720535T2 (de) 2004-03-04

Family

ID=25120175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69720535T Expired - Fee Related DE69720535T2 (de) 1997-01-08 1997-12-29 Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon

Country Status (12)

Country Link
US (1) US5811452A (de)
EP (1) EP0966456B1 (de)
JP (1) JP2001509150A (de)
KR (1) KR20000069887A (de)
AT (1) ATE236143T1 (de)
AU (1) AU738536B2 (de)
BR (1) BR9714272A (de)
CA (1) CA2276483A1 (de)
DE (1) DE69720535T2 (de)
ES (1) ES2196393T3 (de)
IL (1) IL130669A0 (de)
WO (1) WO1998030553A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005120A (en) 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6020507A (en) * 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
NZ517772A (en) * 1999-11-24 2004-03-26 Immunogen Inc Cytotoxic agents comprising taxanes and their therapeutic use
NZ514407A (en) * 2000-02-02 2004-12-24 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents
CN1362876A (zh) * 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10杂取代的乙酸基紫衫烷抗肿瘤剂
PT1165549E (pt) * 2000-02-02 2008-06-20 Univ Florida State Res Found Taxanos substituídos em c7 por carbamoíloxi como agentes anti-tumorais
JP2003522170A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ７カーボネート置換タキサン
JP2003522171A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ１０カーボネート置換タキサン
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CN1362957A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷
WO2002022159A1 (en) 2000-09-11 2002-03-21 Therapro Technologies, Inc. Thionin as an antineoplastic and immunostimulant
ITMI20012186A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012185A1 (it) 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
AU2003256847A1 (en) * 2002-07-26 2004-02-16 Advanced Research And Technology Institute At Indiana University Method of treating cancer
US7390898B2 (en) * 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
CA2494074A1 (en) * 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
AU2003273671A1 (en) * 2002-10-09 2004-05-04 Phytogen Life Sciences, Inc. Novel taxanes and methods related to use and preparation thereof
WO2004032923A1 (en) * 2002-10-11 2004-04-22 Dana-Farber Cancer Institute Inc Epothilone derivatives for the treatment of multiple myeloma
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
HN2005000054A (es) * 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
AU2006214498A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
PL1871753T3 (pl) * 2005-03-31 2012-12-31 Accord Healthcare Inc Wytwarzanie taksanów z 9-dihydro-13-acetylobakatyny iii
ES2389518T3 (es) 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン
KR20210100223A (ko) 2008-04-30 2021-08-13 이뮤노젠 아이엔씨 가교제 및 그 용도
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
PT3122757T (pt) 2014-02-28 2023-11-03 Hangzhou Dac Biotech Co Ltd Ligantes carregados e as suas utilizações em conjugação
EP3319936A4 (de) 2015-07-12 2019-02-06 Suzhou M-conj Biotech Co., Ltd. Brückenlinker zur konjugation von zellbindenden molekülen
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
JP7138350B2 (ja) 2016-11-14 2022-09-16 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． 共役連結体、該連結体を含有する細胞結合分子－薬物共役体、並びに該共役体及び連結体の使用及び製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5350866A (en) * 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
EP0966456A1 (de) 1999-12-29
WO1998030553A1 (en) 1998-07-16
KR20000069887A (ko) 2000-11-25
US5811452A (en) 1998-09-22
AU5903798A (en) 1998-08-03
IL130669A0 (en) 2000-06-01
AU738536B2 (en) 2001-09-20
ATE236143T1 (de) 2003-04-15
JP2001509150A (ja) 2001-07-10
DE69720535T2 (de) 2004-03-04
ES2196393T3 (es) 2003-12-16
BR9714272A (pt) 2000-04-18
CA2276483A1 (en) 1998-07-16
EP0966456A4 (de) 2000-07-26
EP0966456B1 (de) 2003-04-02

Similar Documents

Publication Publication Date Title
DE69720535D1 (de) Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0314354A (pt) Formação para gentes lipofìlicos
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
ME00017B (me) Derivati kamptotecina koji imaju antitumorno dejstvo
DK0649410T3 (da) Anilidderivater.
DE69323549T2 (de) Topisch anwendbare arzneimittel, enthaltend toremifen und dessen metabolite
BR9801652A (pt) Resorcinil-triazinas
HUP0104273A2 (hu) Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
EP0824915A3 (de) Herstellung von Glycoglycerolipiden, deren Verwendung als Tenside sowie kosmetische oder dermatologische Zubereitungen, solche Glycoglycerolipide enthaltend
ATE247953T1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
DE68902301T2 (de) Diarylverbindungen als antiatherosklerotische mittel.
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
ATE146361T1 (de) Therapeutische mittel für die behandlungder resistenz gegen arzneimittel bei krebs
DE60221537D1 (de) Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität
ES2058228T3 (es) Compuestos activos sobre el sistema cardiovascular.
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
DE60005517D1 (de) Kaliumkanal-blockierende mittel
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
FR2789588B1 (fr) Utilisation d'une proteine ompa d'enterobacterie associee a un antigene dans une composition pharmaceutique destinee a generer ou accroitre une reponse cytotoxique antivirale, antiparasitaire ou antitumorale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee